Correlation Between Lockheed Martin and Pfizer

Can any of the company-specific risk be diversified away by investing in both Lockheed Martin and Pfizer at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lockheed Martin and Pfizer into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lockheed Martin and Pfizer Inc, you can compare the effects of market volatilities on Lockheed Martin and Pfizer and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lockheed Martin with a short position of Pfizer. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lockheed Martin and Pfizer.

Diversification Opportunities for Lockheed Martin and Pfizer

-0.32

Correlation Coefficient

Lockheed Martin  Pfizer

Very good diversification

The 3 months correlation between Lockheed and Pfizer is -0.32. Overlapping area represents the amount of risk that can be diversified away by holding Lockheed Martin and Pfizer Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Pfizer Inc and Lockheed Martin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lockheed Martin are associated (or correlated) with Pfizer. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Pfizer Inc has no effect on the direction of Lockheed Martin i.e., Lockheed Martin and Pfizer go up and down completely randomly.

Pair Corralation between Lockheed Martin and Pfizer

Considering the 90-day investment horizon Lockheed Martin is expected to generate 0.5 times more return on investment than Pfizer. However, Lockheed Martin is 1.99 times less risky than Pfizer. It trades about 0.24 of its potential returns per unit of risk. Pfizer Inc is currently generating about -0.08 per unit of risk. If you would invest  42,798  in Lockheed Martin on January 24, 2024 and sell it today you would earn a total of  3,210  from holding Lockheed Martin or generate 7.5% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Lockheed Martin  vs.  Pfizer Inc

Lockheed Martin

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Lockheed Martin are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak primary indicators, Lockheed Martin may actually be approaching a critical reversion point that can send shares even higher in May 2024.

Pfizer Inc

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Pfizer Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Pfizer is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Lockheed Martin and Pfizer

The main advantage of trading using opposite Lockheed Martin and Pfizer positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lockheed Martin position performs unexpectedly, Pfizer can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Pfizer will offset losses from the drop in Pfizer's long position.

The idea behind Lockheed Martin and Pfizer Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.